Skip to main content
. 2019 Feb 14;14(2):e0212291. doi: 10.1371/journal.pone.0212291

Table 1. Codes set descriptions and sizes, the size of the related inclusion/exclusion term sets, and the inclusion/exclusion term sizes as proportions of the original code set size.

Proportions ≤ 100% are displayed in bold.

Cohort definition code sets Code set size Number of inclusion terms Number of exclusion terms Number of inclusion and exclusion terms as % of code set size
Type 2 diabetes mellitus [19] 116 5 9 12.1%
Cancer except non-melanoma skin cancer [20] 1395 67 144 15.1%
Total knee replacement [21] 40 2 8 25%
Polymyalgia rheumatic [22] 3 1 0 33.3%
Asthma specific [23] 120 4 51 45.8%
Hidradenitis suppurativa (HS) [24] 2 1 0 50%
Shortness of breath excluded [5] 29 11 4 51.7%
Shortness of breath [5] 48 11 14 52.1%
Dementia [25] 74 8 31 52.7%
Non acute heart failure [26] 40 22 0 55%
Ethnicity [27] 183 46 63 59.6%
Potential hospitalized infections [28] 3219 1383 537 59.6%
Tuberculosis [29] 151 4 95 65.6%
Shoulder dislocation [30] 18 2 10 66.7%
Country of birth [27] 467 241 88 70.4%
Giant cell arteritis [22] 7 4 1 71.4%
Type 1 diabetes mellitus [31] 35 4 25 82.9%
Psoriatic arthritis [32] 7 5 1 85.7%
Possible undiagnosed HS [24] 47 40 2 89.4%
Religion [27] 112 72 29 90.2%
Fragility fracture [33] 18 3 14 94.4%
Rheumatoid arthritis [34] 57 13 42 96.5%
Living alone [27] 65 39 25 98.5%
Colorectal cancer [35] 23 9 14 100%
Stevens-Johnson syndrome [36] 1 1 0 100%
Toxic epidermal necrolysis [36] 5 4 1 100%
Myotonic dystrophy type 1 [37] 2 2 0 100%
Marital status [27] 148 34 131 111.5%
Cohabitation [27] 85 22 79 118.8%
Residence [27] 168 92 111 120.1%
Heart failure [26] 55 20 48 123.6%
HHS Vulnerability Disclosure